Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monitoring of HIV-1–infected patients on antiretroviral therapy and methadone maintenance
2005-000307-33Phase 4Active
- Sponsor
- Sogaisida
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of nevirapine in Human immunodeficiency virus infection type 1, sponsored by Sogaisida. Primary endpoint: Incidence of withdrawal syndrome. Started Sep 2005; status: active.
02
Drugs
nevirapine
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2005-000307-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000307-33.